vimarsana.com

Page 7 - மகாத்மா காந்தி நிறுவனம் ஆஃப் மருத்துவ அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 Has Pushed India s Junior Doctors To Their Limits

COVID-19 Has Pushed India s Junior Doctors To Their Limits
northernpublicradio.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northernpublicradio.org Daily Mail and Mail on Sunday newspapers.

COVID-19 Has Pushed India s Junior Doctors To Their Limits

COVID-19 Has Pushed India s Junior Doctors To Their Limits
krcu.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from krcu.org Daily Mail and Mail on Sunday newspapers.

COVID-19 Has Pushed India s Junior Doctors To Their Limits

COVID-19 Has Pushed India s Junior Doctors To Their Limits
aspenpublicradio.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aspenpublicradio.org Daily Mail and Mail on Sunday newspapers.

India s Drug Regulator Has Approved DRDO s New COVID Drug on Missing Evidence

Healthcare workers transfer the body of a person who died from COVID-19, at a hospital in Kolkata, May 12, 2021. Photo: Reuters/Rupak De Chowdhuri Mumbai: On May 1, the Drug Controller General of India (DCGI) approved a drug called 2-deoxy-d-glucose (2-DG) for emergency use among people with moderate and severe COVID-19, to help manage the disease. This drug was jointly developed by researchers at the Institute of Nuclear Medicine and Allied Sciences, which falls under the Defence Research & Development Organisation (DRDO), and the pharmaceutical giant Dr Reddy’s Laboratories. In line with the DCGI’s approval for favipiravir, itolizumab and Verafin, the approval for 2-DG is based on poor evidence.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.